These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 31907109)

  • 1. Copper(II) complex-loaded castor oil-based nanostructured lipid carriers used against
    Sato MR; Oshiro-Junior JA; Souza PC; Campos DL; Pereira-Da-Silva MA; Pavan FR; Da Silva PB; Chorilli M
    Pharmazie; 2019 Dec; 74(12):715-720. PubMed ID: 31907109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructured lipid carriers for incorporation of copper(II) complexes to be used against
    Sato MR; Oshiro Junior JA; Machado RT; de Souza PC; Campos DL; Pavan FR; da Silva PB; Chorilli M
    Drug Des Devel Ther; 2017; 11():909-921. PubMed ID: 28356717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In Vitro Activity of Copper(II) Complexes, Loaded or Unloaded into a Nanostructured Lipid System, against Mycobacterium tuberculosis.
    Silva PB; Souza PC; Calixto GM; Lopes Ede O; Frem RC; Netto AV; Mauro AE; Pavan FR; Chorilli M
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27196901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Nanostructured Lipid System as a Strategy to Improve the in Vitro Antibacterial Activity of Copper(II) Complexes.
    da Silva PB; Bonifácio BV; Frem RC; Godoy Netto AV; Mauro AE; Ferreira AM; Lopes Ede O; Raddi MS; Bauab TM; Pavan FR; Chorilli M
    Molecules; 2015 Dec; 20(12):22534-45. PubMed ID: 26694337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation of Salicylic Acid Loaded Nanostructured Lipid Carriers Using Box-Behnken Design: Optimization, Characterization and Physicochemical Stability.
    Pantub K; Wongtrakul P; Janwitayanuchit W
    J Oleo Sci; 2017; 66(12):1311-1319. PubMed ID: 29199206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phthalocyanine-loaded nanostructured lipid carriers functionalized with folic acid for photodynamic therapy.
    Oshiro-Junior JA; Sato MR; Boni FI; Santos KLM; de Oliveira KT; de Freitas LM; Fontana CR; Nicholas D; McHale A; Callan JF; Chorilli M
    Mater Sci Eng C Mater Biol Appl; 2020 Mar; 108():110462. PubMed ID: 31923986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanostructured lipid carriers versus microemulsions for delivery of the poorly water-soluble drug luteolin.
    Liu Y; Wang L; Zhao Y; He M; Zhang X; Niu M; Feng N
    Int J Pharm; 2014 Dec; 476(1-2):169-77. PubMed ID: 25280882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation and characteristics of oridonin-loaded nanostructured lipid carriers as a controlled-release delivery system.
    Dai W; Zhang D; Duan C; Jia L; Wang Y; Feng F; Zhang Q
    J Microencapsul; 2010 May; 27(3):234-41. PubMed ID: 20113167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers.
    Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A
    Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced oral bioavailability of an antipsychotic drug through nanostructured lipid carriers.
    Jawahar N; Hingarh PK; Arun R; Selvaraj J; Anbarasan A; S S; G N
    Int J Biol Macromol; 2018 Apr; 110():269-275. PubMed ID: 29402457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of nanostructured lipid carriers as drug delivery system: Influence of liquid lipid types on loading and cytotoxicity.
    Saedi A; Rostamizadeh K; Parsa M; Dalali N; Ahmadi N
    Chem Phys Lipids; 2018 Nov; 216():65-72. PubMed ID: 30219661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructured lipid systems as a strategy to improve the in vitro cytotoxicity of ruthenium(II) compounds.
    de Freitas ES; da Silva PB; Chorilli M; Batista AA; de Oliveira Lopes E; da Silva MM; Leite CQ; Pavan FR
    Molecules; 2014 May; 19(5):5999-6008. PubMed ID: 24818578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanostructured Lipid Carriers (NLC) as Vehicles for Topical Administration of Sesamol: In Vitro Percutaneous Absorption Study and Evaluation of Antioxidant Activity.
    Puglia C; Lauro MR; Offerta A; Crascì L; Micicchè L; Panico AM; Bonina F; Puglisi G
    Planta Med; 2017 Mar; 83(5):398-404. PubMed ID: 27124246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved yeast delivery of fluconazole with a nanostructured lipid carrier system.
    Kelidari HR; Moazeni M; Babaei R; Saeedi M; Akbari J; Parkoohi PI; Nabili M; Gohar AA; Morteza-Semnani K; Nokhodchi A
    Biomed Pharmacother; 2017 May; 89():83-88. PubMed ID: 28222399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers.
    Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X
    AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved anti-obesity effect of herbal active and endogenous lipids co-loaded lipid nanocarriers: Preparation, in vitro and in vivo evaluation.
    Lacatusu I; Badea N; Udeanu D; Coc L; Pop A; Cioates Negut C; Tanase C; Stan R; Meghea A
    Mater Sci Eng C Mater Biol Appl; 2019 Jun; 99():12-24. PubMed ID: 30889655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binary lipids-based nanostructured lipid carriers for improved oral bioavailability of silymarin.
    Shangguan M; Lu Y; Qi J; Han J; Tian Z; Xie Y; Hu F; Yuan H; Wu W
    J Biomater Appl; 2014 Feb; 28(6):887-96. PubMed ID: 24008629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbamazepine-loaded solid lipid nanoparticles and nanostructured lipid carriers: Physicochemical characterization and in vitro/in vivo evaluation.
    Scioli Montoto S; Sbaraglini ML; Talevi A; Couyoupetrou M; Di Ianni M; Pesce GO; Alvarez VA; Bruno-Blanch LE; Castro GR; Ruiz ME; Islan GA
    Colloids Surf B Biointerfaces; 2018 Jul; 167():73-81. PubMed ID: 29627680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Second generation lipid nanoparticles (NLC) as an oral drug carrier for delivery of lercanidipine hydrochloride.
    Ranpise NS; Korabu SS; Ghodake VN
    Colloids Surf B Biointerfaces; 2014 Apr; 116():81-7. PubMed ID: 24445002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen.
    González-Mira E; Nikolić S; García ML; Egea MA; Souto EB; Calpena AC
    J Pharm Sci; 2011 Jan; 100(1):242-51. PubMed ID: 20575052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.